PRESS-RELEASE ·Filed May 15, 2026

REGN

Regeneron Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago WireGlobeNewswire
Press release: contract
Actionable Insight • Neutral

This is a routine corporate philanthropy press release with zero trading implications. No action required — ignore for investment purposes.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
REGN ▲ +14.46% at T+60d
NEUTRAL call ✓ call won +14.46% · α vs SPY +10.21% · entry $696.20 → $796.84
Entry anchored
May 15, 2026
via day open
T+1d
-9.60%
call -9.60% · α -9.54%
$629.34
settled 5mo ago
T+5d
-8.28%
call -8.28% · α -9.25%
$638.53
settled 4mo ago
T+20d
-11.67%
call -11.67% · α -13.78%
$614.98
settled 4mo ago
T+60d
+14.46%
call +14.46% · α +10.21%
$796.84
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Regeneron announced the winners of its 2026 International Science and Engineering Fair (ISEF), awarding over $7 million in prizes to high school students. This is a philanthropic/PR event with no direct financial impact on Regeneron's business or stock.

Key Facts

  • Regeneron ISEF 2026 awarded over $7 million in prizes to more than 1,700 finalists from 67+ countries
  • Top prize: $100,000 George D. Yancopoulos Innovator Award to Hikaru Kuribayashi for origami-folding simulation software
  • Regeneron's total support for ISEF and Science Talent Search will exceed $300 million from 2017 to 2036
  • No financial results, guidance, or business developments disclosed

Financial Impact

No revenue or earnings impact; $300M total sponsorship commitment through 2036 is a pre-existing, non-material expense for a $74.7B market cap company

Risk Factors

  • None from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (38 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3296082
26 reports for REGN
Performance horizon
85% Hit rate 11 of 13 directional calls best @ T+60▲ +26.47%May 21, 2026
Filters
Rows
Reports for REGN — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
—awaiting T+5——
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$843.47 $781.49▼ −7.35%▼ −6.20%$735.20 (−12.84%)
Aug 24, 2026
5w ago
Court Ruling
BULLISH ★ 5/10
$828.50 $799.08▼ −3.55%▼ −4.02%$735.20 (−11.26%)
Aug 20, 2026
6w ago
Press Release
NEUTRAL ★ 5/10
$826.64 $807.71▼ −2.29%▼ −3.40%$735.20 (−11.06%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$797.99 $840.84▲ +5.37%▲ +5.81%$735.20 (−7.87%)
Aug 11, 2026
7w ago
Court Ruling
BULLISH ★ 5/10
$797.00 $807.57▲ +1.33%▲ +1.73%$735.20 (−7.75%)
Jul 30, 2026
9w ago
8-K
BULLISH ★ 7/10
$738.34 $772.11▲ +4.57%▲ +0.95%$735.20 (−0.43%)
Jul 30, 2026
9w ago
Press Release
BULLISH ★ 7/10
$738.34 $772.11▲ +4.57%▲ +0.95%$735.20 (−0.43%)
Jul 27, 2026
9w ago
Press Release
BEARISH ★ 6/10
$695.18 $759.24▼ −9.21%▼ −6.95%$735.20 (−5.76%)
Jul 17, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$676.69 $651.91▼ −3.66%▼ −2.97%$735.20 (+8.65%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 15, 2026